Cromos Pharma, where the patients are


EFPIA, PhRMA release joint principles for responsible data sharing

Wednesday, July 24, 2013 01:41 PM

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) have endorsed joint “Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers.”

More... »

CRF Health eCOA webinar series

BI, EFSD commit $3.3 million to European diabetes research initiatives

Friday, July 19, 2013 01:27 PM

The Boehringer Ingelheim (BI) and European Foundation for the Study of Diabetes (EFSD) partnership has announced the recipients of its European-wide funding initiative targeted at diabetes research. Totaling $3.3 million, these are the first grants to be awarded as part of the EFSD/Boehringer Ingelheim European Diabetes Research Programs, which aim to stimulate and accelerate European research in diabetes.

More... »

Aesica appoints two business development managers

Monday, July 15, 2013 01:32 PM

Aesica, a global contract development and manufacturing organization (CDMO), has appointed Sven Thomas and David Ross business development managers. They will ensure potential customers are aware of how their manufacturing and development needs can be supported.

More... »

Pfizer invests $130 million in two Irish manufacturing sites

Friday, July 12, 2013 02:12 PM

Pfizer is investing $130 million in two of its Irish manufacturing sites, $100 million in the Grange Castle site in Dublin and $30 million in the Ringaskiddy site in Cork. 

More... »

Genomics England launched, DNA mapping

Wednesday, July 10, 2013 12:16 PM

Genomics England, an organization owned by DH, has launched a personal DNA code project. The personal DNA code—known as a genome—of up to 100,000 patients or infections in patients will be sequenced over the next five years.

More... »

The Royal Liverpool University Hospital achieves highest level of accreditation

Wednesday, July 3, 2013 02:20 PM

The Covance-Royal Liverpool University Hospital Clinical Research Unit (the Royal)—has become the first National Health Service (NHS) facility in England to be granted Medicines and Healthcare products Regulatory Agency (MHRA) standard and supplementary phase I accreditation.

More... »

Heptares grants Shire worldwide NDC license

Wednesday, July 3, 2013 10:00 AM

Shire has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares Therapeutics, currently in preclinical development. Adenosine A2A is a G-protein coupled receptor (GPCR) involved in the regulation of dopaminergic pathways in the brain. Inhibition of the A2A receptor is a validated mechanism in the treatment of CNS disorders.

More... »

Report: British patients participating in clinical research at highest level in six years

Tuesday, July 2, 2013 03:15 PM

A new report released by the National Institute for Health Research Clinical Research Network (the clinical research delivery arm of the NHS) shows that more than 630,000 NHS patients in England took part in clinical research studies last year—the highest level since the Network began keeping track six years ago.

More... »

Karolinska Development, Novo Seeds and Finnvera invest in Forendo Pharma

Wednesday, June 26, 2013 02:53 PM

Karolinska Development has invested in Forendo Pharma, a new drug development company based in Finland, together with Novo Seeds and Finnvera.

More... »

AmVac receives two E.U. grants for development of novel vaccines

Tuesday, June 25, 2013 09:37 AM

Biopharmaceutical AmVac has announced that the E.U. approved two grant applications under the seventh framework program (FP7) for the development of vaccines against flu and leishmaniasis. The projects are joint initiatives of AmVac, other European companies and research institutes with expertise in vaccine design and development. Total funding for all participating partners is approximately $7.8 million and $7.2 million, respectively, over five years. Within the funding periods, both vaccines are expected to complete phase I clinical trials.

More... »

CenterWatch Data Library



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs